Latest Close
$1.38
News
AKBA
Akebia Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to AKBA.
1y Change
-$0.50 (-26.60%)
Market Cap
$369,673,344.00
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Recommendation
strong_buy
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Apr 2, 2026
Read articleAkebia Therapeutics R&D Day: Vafseo Growth Plan, Praliciguat Phase 2, New Kidney Pipeline Targets
MarketBeat • Apr 2, 2026
Read articleAkebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
GlobeNewswire • Apr 1, 2026
Read articleGuardian Pharmacy (GRDN) Soars 9.1%: Is Further Upside Left in the Stock?
Zacks • Mar 31, 2026
Read articleIs Akebia Therapeutics (AKBA) One of the Best Penny Stocks to Buy
Insider Monkey • Mar 31, 2026
Read articleAkebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
GlobeNewswire • Mar 19, 2026
Read article